RAC Post-Market Requirements 1 — Questions and Answers
Question 1: What is pharmacovigilance?
- Marketing surveillance
- Post-approval testing
- Monitoring drug safety after approval (Correct answer)
- Advertising compliance
Correct answer: Monitoring drug safety after approval
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. It is a crucial post-marketing activity that involves continuously monitoring the safety of medicines once they are available to the public. This ongoing surveillance helps identify new or rare adverse reactions that may not have been detected during clinical trials.
Question 2: Which form is submitted to the FDA to report an adverse drug event?
- Form FDA 356h
- Form FDA 1571
- Form FDA 3500 (Correct answer)
- Form 483
Correct answer: Form FDA 3500
Form FDA 3500, also known as the MedWatch Voluntary Reporting Form, is the primary form used by healthcare professionals and consumers to report serious adverse events, product problems, or quality issues with medical products. This includes drugs, biologics, and medical devices. It is essential for the FDA's pharmacovigilance efforts to monitor product safety once on the market.
Question 3: What is the purpose of Risk Evaluation and Mitigation Strategies (REMS)?
- Speed up clinical trials
- Encourage over-the-counter use
- Ensure safe use of high-risk medications (Correct answer)
- Simplify manufacturing
Correct answer: Ensure safe use of high-risk medications
Risk Evaluation and Mitigation Strategies (REMS) are programs required by the FDA for certain high-risk medications to ensure that the benefits of the drug outweigh its risks. REMS programs can include elements like patient registries, specialized training for prescribers, or restricted distribution systems. Their primary goal is to mitigate specific serious risks and promote the safe use of these drugs.
Question 4: Which of the following is part of post-market surveillance for medical devices?
- Device classification
- IDE submission
- Post-market surveillance and reporting (Correct answer)
- Patent renewal
Correct answer: Post-market surveillance and reporting
Post-market surveillance and reporting is a critical component of medical device regulation that occurs after a device has been cleared or approved for commercial distribution. This involves ongoing monitoring of device safety and effectiveness, including adverse event reporting and analyzing performance data. These activities help identify potential problems that may not have been apparent during pre-market review.
Question 5: What is a Class I recall?
- Cosmetic labeling issue
- Technical specification update
- Potentially serious health risk (Correct answer)
- Voluntary return for review
Correct answer: Potentially serious health risk
A Class I recall is the most serious type of recall issued by the FDA, indicating that there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. These recalls are initiated when a product poses a significant and immediate threat to public health. They require immediate action to remove the product from the market.
Question 6: Which post-market requirement ensures continued compliance with good manufacturing practices?
- Patent check
- Marketing approval
- FDA inspections and audits (Correct answer)
- Annual sales report
Correct answer: FDA inspections and audits
FDA inspections and audits are crucial post-market requirements that ensure pharmaceutical manufacturers and medical device companies continue to comply with Good Manufacturing Practices (GMP) and other regulatory standards. These routine or for-cause inspections verify that products are consistently produced and controlled according to quality standards. This ongoing oversight helps maintain product quality and safety after initial marketing approval.
RAC Post-Market Requirements 1
What is pharmacovigilance?